Loading...
ResMed Inc.
RMD•NYSE
HealthcareMedical - Instruments & Supplies
$252.27
$2.58(1.03%)
ResMed Inc. (RMD) Financial Performance & Statements
Review ResMed Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
10.95%
↑ 10.95%
Operating Income Growth
16.61%
↑ 16.61%
Net Income Growth
13.75%
↑ 13.75%
Operating Cash Flow Growth
102.11%
↑ 102.11%
Operating Margin
32.10%
↑ 32.10%
Gross Margin
58.53%
↑ 58.53%
Net Profit Margin
26.15%
↑ 26.15%
ROE
25.18%
↑ 25.18%
ROIC
24.33%
↑ 24.33%
ResMed Inc. (RMD) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for ResMed Inc. stock.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $1.28B | $1.22B | $1.22B | $1.20B |
| Cost of Revenue | $530.81M | $507.29M | $518.93M | $515.40M |
| Gross Profit | $751.27M | $717.22M | $704.27M | $681.58M |
| Gross Profit Ratio | $0.59 | $0.59 | $0.58 | $0.57 |
| R&D Expenses | $81.37M | $79.52M | $80.86M | $77.07M |
| SG&A Expenses | $241.61M | $238.98M | $242.19M | $229.92M |
| Operating Expenses | $334.03M | $329.91M | $323.05M | $306.99M |
| Total Costs & Expenses | $864.85M | $837.20M | $841.98M | $822.40M |
| Interest Income | $0.00 | $0.00 | $3.63M | $3.35M |
| Interest Expense | -$2.44M | $0.00 | $9.55M | $14.38M |
| Depreciation & Amortization | -$53.71M | $53.71M | $54.75M | $54.64M |
| EBITDA | $362.18M | $442.71M | $422.04M | $429.23M |
| EBITDA Ratio | $0.28 | $0.36 | $0.35 | $0.36 |
| Operating Income | $417.24M | $387.31M | $381.22M | $374.58M |
| Operating Income Ratio | $0.33 | $0.32 | $0.31 | $0.31 |
| Other Income/Expenses (Net) | $1.08M | -$3.81M | -$23.48M | $837000.00 |
| Income Before Tax | $418.32M | $383.50M | $357.73M | $375.42M |
| Income Before Tax Ratio | $0.33 | $0.31 | $0.29 | $0.31 |
| Income Tax Expense | $73.70M | $72.14M | $65.50M | $74.93M |
| Net Income | $344.62M | $311.36M | $292.24M | $300.49M |
| Net Income Ratio | $0.27 | $0.25 | $0.24 | $0.25 |
| EPS | $2.43 | $2.12 | $1.99 | $2.04 |
| Diluted EPS | $2.34 | $2.11 | $1.98 | $2.04 |
| Weighted Avg Shares Outstanding | $146.86M | $146.86M | $146.91M | $146.96M |
| Weighted Avg Shares Outstanding (Diluted) | $147.60M | $147.60M | $147.53M | $147.45M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan